Palisade Bio Inc (PALI)

May 23, 2026

PALI Q1 2026 Earnings: EPS Misses Estimates as Palisade Bio Advances Pipeline EffortsGuidance Downgrade Alert - Newser

May 23, 2026

May 23, 2026

PALI Should I Buy - Intellectia AI

May 23, 2026

May 22, 2026

[EFFECT] PALISADE BIO, INC. SEC Filing - Stock Titan

May 22, 2026

May 20, 2026

Palisade Bio, Inc.Common Stock (NQ: PALI - FinancialContent

May 20, 2026

May 18, 2026

Palisade Bio Records Q1 Earnings and Advances Clinical Pipeline - HarianBasis.co

May 18, 2026

May 18, 2026

Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M - Yahoo Finance

May 18, 2026

May 17, 2026

Number of shareholders of Palisade Bio, Inc. – MUN:7NS0 - TradingView

May 17, 2026

May 16, 2026

10 Best NASDAQ Stocks Under $5 to Buy Right Now - Insider Monkey

May 16, 2026

May 15, 2026

RA Capital and partners disclose 9.99% stake in Palisade Bio (PALI) via warrants and shares - Stock Titan

May 15, 2026

May 15, 2026

[SCHEDULE 13G/A] PALISADE BIO, INC. Amended Passive Investment Disclosure - Stock Titan

May 15, 2026

May 15, 2026

Commodore Capital reports 12.37M-share stake in Palisade Bio (PALI) - Stock Titan

May 15, 2026

May 15, 2026

Perceptive Advisors (NASDAQ: PALI) reports a 7.9% collective stake in Palisade Bio - Stock Titan

May 15, 2026

May 15, 2026

Ameriprise/Columbia disclose 8.71M-share stake in Palisade Bio (NASDAQ: PALI) - Stock Titan

May 15, 2026

May 15, 2026

We're Not Worried About Palisade Bio's (NASDAQ:PALI) Cash Burn - Yahoo Finance

May 15, 2026

May 14, 2026

Analysts Are Bullish on These Healthcare Stocks: BridgeBio Pharma (BBIO), Palisade Bio (PALI) - The Globe and Mail

May 14, 2026

May 12, 2026

Palisade Bio Incmay offer and sell up to $300 million of securitiesSEC filing - marketscreener.com

May 12, 2026

May 12, 2026

Palisade Bio (NASDAQ: PALI) files $300M shelf to offer securities - Stock Titan

May 12, 2026

May 12, 2026

Palisade Bio Q1 net loss widens on higher R&D costs - TradingView

May 12, 2026

May 12, 2026

Palisade Bio (PALI) ramps PALI-2108 trials with $132.6M cash runway - Stock Titan

May 12, 2026

May 12, 2026

BRIEF-Palisade Bio Q1 EPS USD -0.05 - TradingView

May 12, 2026

May 12, 2026

Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108 - GlobeNewswire

May 12, 2026

May 12, 2026

Palisade Bio (NASDAQ: PALI) boosts R&D spend to advance PALI-2108 - Stock Titan

May 12, 2026

May 12, 2026

Palisade Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 12, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 08, 2026

Palisade Bio Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView

May 08, 2026

May 06, 2026

Palisade Bio (PALI) price target decreased by 12.09% to 10.20 - MSN

May 06, 2026

May 06, 2026

Palisade Bio, Inc. (NASDAQ:PALI) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

May 06, 2026

May 05, 2026

Palisade Bio Data Supports Once-Daily Ulcerative Colitis Treatment Due to Sustained IC90 Coverage - geneonline.com

May 05, 2026

May 05, 2026

Palisade Bio presents pharmacokinetic data for ulcerative colitis drug By Investing.com - Investing.com South Africa

May 05, 2026

May 05, 2026

Palisade Bio presents pharmacokinetic data for ulcerative colitis drug - Investing.com

May 05, 2026

May 05, 2026

Palisade UC pill stayed above IC90 through the dosing interval - Stock Titan

May 05, 2026

May 04, 2026

MSN Money - MSN

May 04, 2026

May 04, 2026

Palisade Bio (PALI) Expected to Announce Earnings on Monday - MarketBeat

May 04, 2026

May 03, 2026

What Palisade Bio (PALI) capital allocation tells us | Q4 2025: Earnings Beat EstimatesExpert Momentum Signals - Newser

May 03, 2026

Apr 29, 2026

Major share increase and equity plan votes ahead for Palisade Bio (NASDAQ: PALI) - Stock Titan

Apr 29, 2026

Apr 28, 2026

Palisade Bio Participates in Virtual Investor "What This Means" Segment - 富途牛牛

Apr 28, 2026

Apr 27, 2026

Here's Why Palisade Bio (PALI) Could be Great Choice for a Bottom Fisher - MSN

Apr 27, 2026

Apr 22, 2026

PALI Palisade Bio posts narrower than expected Q4 2025 loss, shares gain more than four percent.Secondary Offering - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 22, 2026

12 Health Care Stocks Moving In Wednesday's Intraday SessionAxe Compute (NASDAQ:AGPU), Akanda (NASDAQ - Benzinga

Apr 22, 2026

Apr 21, 2026

Analysts Offer Predictions for Palisade Bio Q1 Earnings - MarketBeat

Apr 21, 2026

Apr 20, 2026

Brokers Issue Forecasts for Palisade Bio Q3 Earnings - MarketBeat

Apr 20, 2026

Apr 17, 2026

Palisade Bio (NASDAQ: PALI) asks shareholders to lift authorized shares to 450M - Stock Titan

Apr 17, 2026